The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results.
Table of Contents |
skim chapter | |
|---|---|---|
| Front Matter | i-xvi | |
| Summary | 1-18 | |
| 1 Introduction | 19-31 | |
| 2 Genomics, Proteomics, and the Changing Research Environment | 32-69 | |
| 3 The U.S. Patent System, Biotechnology, and the Courts | 70-99 | |
| 4 Trends in the Patenting and Licensing of Genomic and Protein Inventions and Their Impact on Biomedical Research | 100-132 | |
| 5 Conclusions and Recommendations | 133-149 | |
| References | 150-154 | |
| Appendix A Biographical Information of Committee and Staff | 155-168 | |
| Appendix B Search Algorithms Used to Identify Patents of Interest | 169-172 | |
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Loading stats for Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health...
Finding similar items...
